PALATINI, PIETRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.087
AS - Asia 2.443
EU - Europa 1.431
AF - Africa 586
SA - Sud America 500
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 28
Totale 12.133
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.773
SG - Singapore 898
CN - Cina 431
HK - Hong Kong 314
BR - Brasile 301
DE - Germania 174
VN - Vietnam 173
FI - Finlandia 165
IT - Italia 123
UA - Ucraina 98
SE - Svezia 86
GB - Regno Unito 81
FR - Francia 74
PL - Polonia 68
RU - Federazione Russa 65
NL - Olanda 47
PK - Pakistan 37
IN - India 33
MX - Messico 32
AE - Emirati Arabi Uniti 29
AR - Argentina 29
BE - Belgio 27
TN - Tunisia 27
PA - Panama 26
SK - Slovacchia (Repubblica Slovacca) 26
ID - Indonesia 25
TR - Turchia 25
RS - Serbia 24
CO - Colombia 23
IQ - Iraq 23
EC - Ecuador 22
SN - Senegal 22
UZ - Uzbekistan 22
YT - Mayotte 22
CL - Cile 21
EG - Egitto 21
GT - Guatemala 21
IE - Irlanda 21
JO - Giordania 21
PT - Portogallo 21
SI - Slovenia 21
AO - Angola 20
BO - Bolivia 20
LB - Libano 20
NP - Nepal 20
PH - Filippine 20
TT - Trinidad e Tobago 20
UY - Uruguay 20
YE - Yemen 20
BW - Botswana 19
CR - Costa Rica 19
IR - Iran 19
KR - Corea 19
KZ - Kazakistan 19
LU - Lussemburgo 19
MU - Mauritius 19
PY - Paraguay 19
CG - Congo 18
CV - Capo Verde 18
KG - Kirghizistan 18
AL - Albania 17
BY - Bielorussia 17
CI - Costa d'Avorio 17
DK - Danimarca 17
GP - Guadalupe 17
GR - Grecia 17
KH - Cambogia 17
MK - Macedonia 17
ML - Mali 17
MY - Malesia 17
PS - Palestinian Territory 17
SA - Arabia Saudita 17
TH - Thailandia 17
VE - Venezuela 17
ZA - Sudafrica 17
CH - Svizzera 16
CZ - Repubblica Ceca 16
DJ - Gibuti 16
DO - Repubblica Dominicana 16
DZ - Algeria 16
EE - Estonia 16
ES - Italia 16
ET - Etiopia 16
GE - Georgia 16
GF - Guiana Francese 16
HR - Croazia 16
LY - Libia 16
AF - Afghanistan, Repubblica islamica di 15
AM - Armenia 15
BB - Barbados 15
CD - Congo 15
CY - Cipro 15
NC - Nuova Caledonia 15
BJ - Benin 14
JM - Giamaica 14
MZ - Mozambico 14
NE - Niger 14
NO - Norvegia 14
RO - Romania 14
RW - Ruanda 14
Totale 11.493
Salva come PNG Salva come JPEG
Città #
Fairfield 881
Woodbridge 776
Ann Arbor 648
Houston 552
Ashburn 551
Singapore 528
Chandler 482
Jacksonville 374
Wilmington 306
Hong Kong 293
Seattle 284
Cambridge 276
Santa Clara 169
Princeton 157
Boardman 139
Beijing 102
San Diego 88
Roxbury 83
Nanjing 64
Medford 55
Dong Ket 52
Helsinki 50
Ho Chi Minh City 50
Padova 49
Bytom 46
Des Moines 40
Munich 39
New York 36
Shenyang 31
Los Angeles 27
Chicago 25
Panama City 25
Hanoi 24
Nanchang 23
Dakar 22
Tianjin 20
Amman 19
São Paulo 19
Tashkent 19
Abidjan 17
Bamako 17
Bishkek 17
Guatemala City 17
Hebei 17
London 17
Phnom Penh 17
Dublin 16
Guangzhou 16
Montevideo 16
Norwalk 16
Bridgetown 15
Jinan 15
Ljubljana 15
Luanda 15
Noumea 15
Kigali 14
Praia 14
San José 14
Cotonou 13
Djibouti 13
Gaborone 13
Kinshasa 13
Luxembourg 13
Managua 13
Maputo 13
Niamey 13
Salt Lake City 13
Yerevan 13
Accra 12
Athens 12
Conakry 12
Havana 12
Kampala 12
Libreville 12
Mamoudzou 12
Pristina 12
Tripoli 12
Turku 12
Addis Ababa 11
Bangkok 11
Buffalo 11
Castries 11
Dushanbe 11
Hefei 11
Lusaka 11
Reykjavik 11
Rio de Janeiro 11
Tallinn 11
Tirana 11
Zurich 11
Baku 10
Banjul 10
Chisinau 10
Detroit 10
Kuala Lumpur 10
Les Abymes 10
Milan 10
Quito 10
Rawalpindi 10
Sanaa 10
Totale 8.206
Salva come PNG Salva come JPEG
Nome #
Severe Liver Cirrhosis Markedly Reduces AhR-Mediated Induction of Cytochrome P450 in Rats by Decreasing the Transcription of Target Genes 232
In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomes 213
Biological and pharmacological properties of phospholipids. 211
Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes 201
Expression and distribution of the adrenomedullin system in newborn human thymus. 197
Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro. 192
A comparison between different methods for the determination of reduced and oxidized glutathione in mammalian tissues 189
Coadministration of sirolimus alters tacrolimus pharmacokinetics. 182
An intracellular adrenomedullin system reduces IL-6 release via a NF-kB-mediated, cAMP-independent transcriptional mechanism in rat thymic epithelial cells 181
Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis 174
Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis 171
Pharmacokinetic drug interactions in liver disease: An update 167
Enzyme inhibition and induction in liver disease. 166
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 164
Effect of herpes simplex virus type 1 infection on nucleoside transport in HeLa S3 cells 164
Differential effect of liver cirrhosis on the pregnane X receptor-mediated induction of CYP3A1 and 3A2 in the rat. 163
Inhibition of cytochrome P450 2C8-mediated drug metabolism by the flavonoid diosmetin. 163
Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure 160
Penetration of carumonam into the pleural fluid: comparison of intravenous bolus and constant infusion in rats with experimentally induced pleurisy. 157
Further purification and characterization of the succinyl-CoA:3-hydroxy-3-methylglutarate coenzyme A transferase from rat-liver mitochondria. 157
The effect of liver disease on inhibitory and plasma protein-binding displacement interaction:an update. 155
Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients 155
Synergism between lysophosphatidylserine and the phorbol ester tetradecanoylphorbolacetate in rat mast cells. 149
A reassessment of the optimal sampling time for the MEGX liver function test 149
A Comparative Analysis of the Urinary Excretion Profiles of Mesna and Argimesna Following Oral Administration to Healthy Volunteers 146
Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function 146
Pharmacokinetic characterization of phosphatidylserine liposomes in the rat 144
Irreversible CYP3A Inhibition Accompained by Plasma Protein-Binding Displacement: A Comparative Analysis in Subjects with normal and impaired liver function. 144
Neoral versus Sandimmun in kidney-pancreas transplantation 140
Pharmacokinetics of intraperitoneal cisplatin and doxorubicin 140
Disposition kinetics of phospholipid liposomes. 138
Differential inducing effect of benzo[a]pyrene on gene expression and enzyme activity of cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar rats. 138
Reactivation of a phospholipid-depleted sodium, potassium-stimulated ATPase. 137
The role of residual phospholipids and copurified proteins in the reconstitution of bovine heart mitochondrial ATPase complex. 137
Canrenone as a partial agonist at the digitalis receptor site of (Na+-K+)ATPase 136
Effects of single dose of gamma-hydroxybutyric acid and lorazepam in psychomotor performance and subjective feelings in healthy volunteers 135
The effect of age on plasma MEGX concentrations. 134
Mechanism of local anesthetic effect. Involvement of F0 in the inhibition of mitochondrial ATP synthase by phenothiazines. 132
Enzyme induction is independent on liver functional status 131
Influence of the mode of intravenous administration on the penetration of ceftazidime into tissues and pleural exudate of rats. 131
Liver dysfunction markedly decreases the inhibition of CYP1A2-mediated theophylline metabolism by fluvoxamine 130
Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity 130
Liver dysfunction markedly decreases the inhibition of cytochrome P450IA2-mediated theophylline metabolism by fluvoxamine 129
Role of antioxidant defences in the species-specific response of isolated atria to menadione 128
F1-ATPase from different submitochondrial particles. 128
Effect of gender on the monoethylglycinexylidide test in healthy subjects and patients with liver cirrhosis 126
Mechanism of Na+/K(+)-ATPase activation by trypsin and kallikrein. 126
The pharmacokinetics of teniloxazine in healthy subjects and patients with liver cirrhosis 125
Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis - Phase I study 124
Effect of renal flailure on metabolic disposition of lidocaine in patients undergoing and not undergoing hemodialysis 122
Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis. 121
EFFECTS OF HERPES-SIMPLEX VIRUS TYPE-1 INFECTION ON THE PLASMA- MEMBRANE AND RELATED FUNCTIONS OF HELA S3 CELLS 120
Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. 120
Protective action of cardiac DT-diaphorase against menadione toxicity in guinea pig isolated atria 119
Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis 119
Role of phosphatidylserine and phosphatidylcholine in the dicyclohexylcarbodiimide-induced inhibition of mitochondrial ATPase. 118
Absorption and disposition kinetics of flunoxaprofen and benoxaprofen in healthy volunteers. 118
Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. 118
Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. 117
Nephrotoxic effect of atractyloside in rats. 117
Renal clearance of N-1-Methylnicotinamide is a marker of liver dysfunction in cirrhosis 116
Apomorphine-induced inhibition of histamine release in rat peritoneal mast cells. 116
Pharmacokinetics of miocamycin in patients with liver cirrhosis. 114
The interaction of tricyclic antipsychotics with (Na+-K+)ATPase 113
Anion activation of dopamine beta-hydroxylase: a kinetic model. 110
Reversal by phospholipids of the oligomycin induced inhibition of membrane associated adenosintriphosphatases. 110
A new plot for multiple enzyme inhibition 110
Mechanism of inhibition of sodium- and potassium-dependent adenosine triphosphatase by tricyclic antipsychotics 109
Inhibition of protein kinase activity by apomorphine. 108
Mechanism of local anesthetic effect on mitochondrial ATP synthase as deduced from photolabelling and inhibition studies with phenothiazine derivatives. 107
Needle and trocar injuries in diagnostic laparoscopy under local anesthesia: what is the true incidence of these complications? 104
In vitro inhibition of cytochrome P450 (CYP) 2C8-mediated drug metabolism by the flavonoid diosmetin 103
Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase. 103
[Function of phospholipids in a membranous in a membranous complex with ATPase activity]. 99
The interaction between full and partial inhibitors acting on a single enzyme: a theoretical analysis 95
Fumarate is the cause of the apparent ping-pong kinetics of dopamine beta-hydroxylase. 95
A simple method for discriminating between full and partial inhibitors 95
Effects of chronic renal failure and hemodialysis on the monoethylglycinexylidide liver function test. 94
Mg-dependent inhibition of beef heart soluble mitochondrial ATPase by tricyclic antipsychotics 94
Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis 89
Effect of experimentally induced liver cirrhosis on CYP3A induction in male Wistar rats 87
Evaluation ciprofloxacin and ofloxacin pharmacokinetics in liver cirrhosis. 85
Differential effect of liver dysfunction on CYP3A1 and CYP3A2 expression in rats with carbon tetrachloride-induced cirrhosis 84
Pharmacokinetic interactions between Tacrolimus and Sirolimus in Kidney Transplant recipients 84
Stereospecific disposition of flunoxaprofen enantiomers in human beings. 82
Inhibition of dopamine beta-hydroxylase by captopril. 81
Interazioni farmacocinetiche tra Tacrolimus e Sirolimus nel Trapianto Renale 79
ORAL DISPOSITION KINETICS OF N-(AMINOSULPHONYL)-3-(((DIAMINOETHYLENE) AMINO)-N-THIAZOLYL) METHYLTHIOPROPANIMIDAMIDE (FAMOTIDINE) IN PATIENTS WITH LIVER-CIRRHOSIS 78
Effect of CYP 3A4 inhibition on lidocaine kinetics and the MEGS liver function test 75
Serine phospholipids as endocoids. 69
Pharmacokinetics of gamma hydroxybutyric acid. 68
Effect of liver functional status on the pharmacokinetic interaction between the CYP 1A2 inhibitor fluvoxamine and lidocaine 66
Famotidine pharmacokinetics in the elderly: results of a preliminary study 65
Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid 63
The behaviour of miocamycin kinetics in cirrhotic patients after single and repeated oral administration. 63
Inhibition of enzymes and enzyme by phenothiazines and their radicals. In: Phenothiazienes and 1,4-benzothiazines 62
Totale 12.151
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.494
article - articoli 33.787
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 184
Totale 70.465
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021597 0 0 0 0 0 87 46 89 126 61 95 93
2021/20221.132 35 124 138 87 29 77 48 124 42 36 130 262
2022/2023951 177 132 11 103 166 137 10 59 108 6 30 12
2023/2024326 22 57 36 32 18 30 8 22 6 2 47 46
2024/20251.758 3 146 71 70 293 44 47 119 160 73 307 425
2025/20263.509 200 567 914 1.091 583 154 0 0 0 0 0 0
Totale 12.151